Prof. Wei R. Chen Chairs International Biophotonics Conference
February 19, 2025
Prof. Wei R. Chen, co-inventor of IP-001, Stephenson Chair, professor, and interim director of the Stephenson School of Biomedical Engineering…
BIO CEO & Investor Conference February 10 – 11, 2025
February 6, 2025
Robert Arch, SVP Corporate Development at Immunophotonics, Inc. will be attending the BIO CEO & Investor Conference which will be held on…
SIO Annual Scientific Meeting, January 30 to February 3, 2025
January 29, 2025
Tomas Hode, PhD, Co-Founder, CIO, and President of Immunophotonics, Inc. will be attending the SIO2025 Annual Scientific Meeting January 30…
SPIE Photonics West and BiOS Expo, Jan. 25 – 30, 2025 in San Francisco
January 23, 2025
Tomas Hode, PhD, President & CIO will attend the SPIE, the international society for optics and photonics conferences taking place…
SPECTRUM CONFERENCE, JANUARY 16 – 18, 2025
January 15, 2025
Immunophotonics’ Tomas Hode, PhD (CIO and President) is attending Spectrum Conference, January 16 – 18, in Miami, Florida. Some of…
JPM 2025 San Francisco, January 13 -16, 2025
January 15, 2025
Our networking is well underway with investors and potential strategic partners for JPM2025 in San Francisco, January 13 – 16,…
NCI SBIR Peer Learning and Networking (PLAN) webinar series
November 18, 2024
Lu Alleruzzo, CEO and David Anderson, PhD, CSO of Immunophotonics, are excited to participate in the NCI SBIR Peer Learning…
AngioDynamics International Life Symposium November 7 – 9, 2024
November 5, 2024
Immunophotonics co-founders Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President will attend the AngioDynamics International Life Symposium taking…
Professor Wei Chen’s publication in Elsevier Cancer Letters an international journal
October 16, 2024
Congratulations to Professor Wei Chen and his lab University of Oklahoma for their publication titled “Localized ablative immunotherapy enhances antitumor…
SITC Immuno-Oncology Drug Development Summit September 30 – October 1, 2024
October 3, 2024
Siu Kit “Samuel” Lam, PhD, Senior Vice President of Science & Research at Immunophotonics, Inc. attended the SITC Immuno-Oncology Drug…